Exercise interventions improve cardiometabolic health in people with metabolic syndrome (MetS), but achieving these benefits may depend on weight loss, as shown in a study.
A total of 228 adults (mean age 55.3 years, 42.1 percent female, mean BMI 32.5 kg/m2) with MetS and less than 120 min/wk of moderate-intensity physical activity participated in the study.
The participants were randomly allocated to either the standard-care, nonexercise group (control group, n=58) or the standard-care plus physical activity group (exercise group, n=170). Those in the exercise group underwent a 16-week supervised high-intensity interval training programme, with three 43-min sessions performed each week.
Outcomes included MetS (MetS z-score), insulin resistance (HOMA-IR), cardiorespiratory fitness (VO2PEAK), maximal cycling power (WPEAK), and body weight/composition. These parameters were assessed at baseline and after the intervention.
In the exercise group, 78 participants achieved the weight loss predicted from estimated exercise energy expenditure (−3.3 kg), 38 did not meet the expected weight loss (−0.7 kg), and 54 gained weight (1.1 kg) after 16 weeks.
Compared with the control group, the exercise group showed significant improvement in cardiorespiratory fitness regardless of body weight loss response (p<0.001 for all).
However, only participants who achieved the expected weight loss in the exercise group had significant improvements in MetS z-score (−0.31) and HOMA-IR (−0.7) compared with the control group (p<0.001 for both).